Status:

COMPLETED

Study of Nitazoxanide, Peginterferon, and Ribavirin Combination Therapies in the Treatment of Chronic Hepatitis C

Lead Sponsor:

Romark Laboratories L.C.

Conditions:

Chronic Hepatitis C

Eligibility:

All Genders

18+ years

Phase:

PHASE2

PHASE3

Brief Summary

The purpose of this study is to evaluate the safety and efficacy of nitazoxanide-peginterferon and nitazoxanide-peginterferon-ribavirin combination regimens compared to the standard of care (peginterf...

Eligibility Criteria

Inclusion

  • Age ≥18 years.
  • Chronic hepatitis C infection (at least 6 months) evidenced by a positive enzyme immunoassay for anti-HCV-antibodies and a positive quantitative RT-PCR amplification of HCV RNA.
  • Chronic inflammation on liver biopsy compatible with a diagnosis of chronic viral hepatitis.
  • HCV genotype 4.

Exclusion

  • Patients who have previously failed to respond to ≥12 weeks of peginterferon-ribavirin combination therapy.
  • Females who are either pregnant, breast-feeding or not using birth control and are sexually active.
  • Males whose female partners are pregnant.
  • Patients with other causes of liver disease (i.e., autoimmune hepatitis, decompensated liver disease).
  • Patients co-infected with hepatitis A virus, hepatitis B virus or hepatitis D virus.
  • Patients with a history of alcoholism or with an alcohol consumption of \>40 grams per day.
  • Patients with hemoglobinopathies (i.e., thalassemia major, sickle-cell anemia).
  • Patients with any concomitant condition that, in the opinion of the investigator, would preclude evaluation of response or make it unlikely that the contemplated course of therapy and follow-up could be completed.
  • History of hypersensitivity or intolerance to any of the excipients comprising the nitazoxanide tablets, peginterferon alfa-2a injectionable solution or ribavirin tablets.

Key Trial Info

Start Date :

June 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 1 2008

Estimated Enrollment :

121 Patients enrolled

Trial Details

Trial ID

NCT00421434

Start Date

June 1 2006

End Date

September 1 2008

Last Update

September 25 2008

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Department of Tropical Medicine & Infectious Diseases, Alexandria University

Alexandria, Egypt

2

Department of Tropical Medicine & Infectious Diseases, Tanta University School of Medicine

Tanta, Egypt